The panzootic spread of highly pathogenic avian influenza H5N1 sublineage 188.8.131.52b: a critical appraisal of One Health preparedness and prevention
With the world gradually recovering from the COVID-19 pandemic, it is important to think forward when it comes to prevention of infectious disease outbreaks originating from the animal world.
Omicron BA.2 breakthrough infection elicits CD8+ T cell responses recognizing the spike of later Omicron subvariants
Recent studies have suggested that memory T cells play a critical role in protecting individuals immunized with SARS-CoV-2 vaccines against variants
Determinants of epidemic size and the impacts of lulls in seasonal influenza virus circulation
During the COVID-19 pandemic, levels of seasonal influenza virus circulation were unprecedentedly low, leading to concerns that a lack of exposure to influenza viruses, combined with waning antibody titres.
Inflammageing mediated by cytotoxic lymphocytes is associated with diabetes duration
Type 2 diabetes is associated with increased tumor necrosis factor-α by CD8 T cells. Increased granzyme B production by natural killer cells and γδ T cells is observed in type 2 diabetes.
9th Influenza Conference 2023
ESWI 2023 Conference Science Policy Interface highlights
This report summarises ESWI’s interpretation of the key messages from the individual talks within the Science Policy Interface (SPI) track of the conference
Long COVID: major findings, mechanisms and recommendations
Long COVID is an often debilitating illness that occurs in at least 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.
How well does a flu vaccine work? DRIVE project evaluates performance
Despite challenging conditions posed by the COVID-19 outbreak, the DRIVE project successfully tested how well various brands of flu vaccines worked across five European countries and a range of age groups.
Policy & Recommendations
Data-informed decision-making: Driving life-course immunisation in National Immunisations Programs (NIPs)
CLCI, together with MEP Tomislav Sokol and the European Institute for Innovation through Health Data, has produced a report exploring ways of improving the use of data in national immunisation programme planning.
Real-World Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents
The efficacy of the BNT162b2 vaccine in pediatrics was assessed by randomised trials before the Omicron variant’s emergence.
ESWI Airborne: Life as a scientist
Being a scientist, not just a job
Do not miss the opportunity to listen to this enthusiastic and insightful conversation between Debby van Riel, Carolien van de Sandt and Jenna Guthmiller
Public health action needed to mitigate the impact of respiratory pathogens for 2023-24 winter season in Europe
In an epidemiological update, the ECDC urges EU/EEA Member States to strengthen vaccination campaigns and prepare for the possible need to increase emergency department and ICU capacity
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults
Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality among older adults.